Cargando…
The role of primary retroperitoneal lymph node dissection in the treatment of stage II seminoma
Stage II seminoma is responsive to chemo- or radiotherapy with a progression-free survival of 87–95% at 5 years but at the cost of short- and long-term toxicity. After evidence about these long-term morbidities emerged, four surgical cohorts investigating the role of retroperitoneal lymph node disse...
Autores principales: | Sigg, Silvan, Fankhauser, Christian Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256310/ https://www.ncbi.nlm.nih.gov/pubmed/37144886 http://dx.doi.org/10.1097/MOU.0000000000001099 |
Ejemplares similares
-
Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023
por: Yanagisawa, Takafumi, et al.
Publicado: (2023) -
Role of lymphadenectomy during primary surgery for kidney cancer
por: Bekku, Kensuke, et al.
Publicado: (2023) -
Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
por: Hu, Brian, et al.
Publicado: (2018) -
Retroperitoneal Lymph Node Dissection Should Be a Standard-of-Care Treatment Option For Stage II Seminoma
por: Alsyouf, Muhannad, et al.
Publicado: (2023) -
Retroperitoneal lymph node dissection for germ cell tumour
por: Tran, Vy, et al.
Publicado: (2020)